MedTrace Logo

High Flux Hemodialysis Thrice Versus Once

NCT00714662 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2008-07-14

No results posted yet for this study

Summary

To investigate the influence of different dialysis frequencies on the outcome of end-stage renal disease patients undergoing chronic hemodialysis therapy.

Conditions

  • End-Stage Renal Disease

Interventions

DEVICE

high flux hemodialyzer (FX-60, FX-80 or FX-100)

three sessions per week

Sponsors & Collaborators

  • Mrs. Hsiu-Chin Lee Kidney Research Fund

    collaborator UNKNOWN

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yung-Ming Chen, M.D. · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-02-28
Completion
2009-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00714662 on ClinicalTrials.gov